Wearable Exoskeleton Market : Technological Advancements, Evolving Industry Trends And Insights 2019 – 2025

ResearchMoz presents professional and in-depth study of "Global Wearable Exoskeleton Market Insights, Forecast to 2025".

This report presents the worldwide Wearable Exoskeleton market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1881709

The Wearable Exoskeleton market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Wearable Exoskeleton.

The following manufacturers are covered in this report:

• ReWalk Robotics
• Wearable Robotics
• Sarcos
• Cyberdyne
• Ekso Bionics
• Rex Bionics
• Lockheed Martin
• AlterG
• Hocoma

Wearable Exoskeleton Breakdown Data by Type
Upper Wearable
Lower Wearable
Body Wearable
Wearable Exoskeleton Breakdown Data by Application
Military
Other

Wearable Exoskeleton Production by Region
United States
Europe
China
Japan
Other Regions
Other Regions

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1881709

The study objectives are:
To analyze and research the global Wearable Exoskeleton status and future forecastinvolving, production, revenue, consumption, historical and forecast.
To present the key Wearable Exoskeleton manufacturers, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Wearable Exoskeleton market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Insomnia Market to Witness Astonishing Growth and Developments 2019- 2026

ResearchMoz presents professional and in-depth study of "Insomnia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026".

The contours of the global Insomnia market dynamic are constantly changing, and are shaped by various macroeconomic factors and trends in the healthcare industry. These trends have also changed the directions of investments, especially in emerging markets. In recent years, new frontiers in the Insomnia market have come to the fore propelled by implementation of regulatory norms put forth by governments in developing and developed regions. New healthcare guidelines will likely put a significant bearing on new product developments in nascent as well as established markets over 2017 – 2026 (forecast period). Changing nature of demands of patient populations and rapid technological advances, notably in healthcare IT, are expected to open and support new paradigms in the global Insomnia market.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1558121

According to the Sleep Health Foundation, Insomnia has been estimated to affect over one-third of the global population. Insomnia is characterized on the basis of multiple patterns such as difficulty in sleep initiation & maintenance that is usually accompanied with awakening too early & trouble sleeping again or frequent awakenings. Long-term insomnia has impacted daily life of individuals suffering from the disease, and has been associated with nervous breakdown or severe depression if left untreated. Increasing presence of patented molecules and potential clinical pipeline drug candidates hold promise in the treatment of insomnia. Demand for insomnia therapeutics will witness a tremendous rise on the back of growing geriatric population, and rising stress level among the urban population.

Transparency Market Research (TMR) has published a new insightful report on the global insomnia market. The report delivers forecasts on the global insomnia market, and examines the market in detail, providing important dynamics affecting the market expansion. Along with the provision of information on latest market trends, restraining factors, and augmenting factors impacting growth of the market, analysis on the data regarding multiple market parameters has been included in the report.

Report Structure

The report’s initiates with a chapter titled “executive summary”, which issues a summation of global insomnia market coupled with the information on imperative market numbers such as historical CAGR (2012-2016) and forecast CAGR (2017-2026). These numbers rendered are associated with the market segments incorporated in the report. Trailing the executive summary is a chapter titled “overview” that incorporates the definition of “insomnia”, which succeeds an incisive market introduction. The overview chapter clearly describes the wide scope of global insomnia market. Some chapters in the report offer information on the pricing analysis coupled with the cost structure regarding the global insomnia market.

Competition Landscape

A scrupulous analysis regarding the global insomnia market’s competition landscape has been issued in the concluding chapter of this report, incorporating information on prominent industries that significantly contribute to the market expansion. Occupancy of these market participants is tracked with the aid of an intensity map. Profiling key market participants rigorously, this chapter offers insights based on SWOT analysis, key developments, key financials, company overview, and product overview.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1558121

Research Methodology

A robust research methodology, proven & tested, has been employed by TMR’s analysts to develop the report on global insomnia market. The research methodology used has helped analysts in offering accurate insights related to the global insomnia market. It depends entirely upon the secondary and primary researches, for gaining important information associated with the market. The information compiled has then been validated by the analysts several times for ensuring the report’s authenticity, and for making it a reliable & authoritative source of reference for readers of the report.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ https://www.linkedin.com/showcase/13221461
Follow me on : https://marketinfo247.wordpress.com/

Motion Sickness Treatment Market 2019 Global Newest Industry Data, Future Trends, Key Indicators And Forecast 2026

ResearchMoz presents professional and in-depth study of "Motion Sickness Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026".

The contours of the global Motion Sickness Treatment market dynamic are constantly changing, and are shaped by various macroeconomic factors and trends in the healthcare industry. These trends have also changed the directions of investments, especially in emerging markets. In recent years, new frontiers in the Motion Sickness Treatment market have come to the fore propelled by implementation of regulatory norms put forth by governments in developing and developed regions. New healthcare guidelines will likely put a significant bearing on new product developments in nascent as well as established markets over 2018 – 2026 (forecast period). Changing nature of demands of patient populations and rapid technological advances, notably in healthcare IT, are expected to open and support new paradigms in the global Motion Sickness Treatment market.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1586266

Motion sickness is a common condition characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling. It is caused by difference in impulses received by perceived sense of motion by visual senses and vestibular system’s sense of movement. Conflict among those senses result in motion sickness. Motion sickness is estimated to be experienced by around 50% travelers; it is most widely witnessed among children and elderly people. Various prescription and OTC drugs and products are used to treat motion sickness and provide relief from its symptoms. Anticholinergic, antihistamines, and sympathomimetic are the most commonly used medications, while traditional remedies such as herbal medicines, homeopathic medicines, and others are also available as OTC products for treatment of motion sickness.

The global motion sickness treatment market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on treatment type, route of administration, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market has been provided in the overview section. The report provides key insights of the global motion sickness treatment market comprising global pipeline analysis, key mergers and acquisitions, OTC vs. prescription drug market assessment, and Porter’s Five Forces Analysis. Additionally, the competition landscape section comprises competitive matrix, key player’s market footprint by treatment type and region, key competitive business strategies, and company profiles with business overview to understand the competitive landscape in the market. The report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global motion sickness treatment market.

Global Motion Sickness Treatment Market: Key Segments

Based on treatment type, the global motion sickness treatment market has been segmented into anticholinergic, antihistamines, and others. The report also offers overview of the global motion sickness treatment market based on oral, transdermal, and other routes of administration. The treatment type segments have been analyzed based on commercially available motion sickness treatment drug and product types, route of administration, and adoption of each treatment type. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of distribution channel, the global motion sickness treatment market has been segmented into retail pharmacies, online pharmacies, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Motion Sickness Treatment Market: Regional Outlook

Geographically, the global motion sickness treatment market has been segmented into five major regions and the key countries/sub-regions in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the motion sickness treatment market are GlaxoSmithKline plc, Perrigo Company plc, Prestige Brands, Inc., WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals, Inc., Myungmoon Pharm Co., Ltd., Baxter International, Inc. and Reliefband Technologies LLC.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1586266

The global motion sickness treatment market has been segmented as follows:

Global Motion Sickness Treatment Market, by Treatment Type

• Anticholinergic
• Antihistamines
• Others (sympathomimetic, traditional medicines, wearable relief bands, etc.)

Global Motion Sickness Treatment Market, by Route of Administration

• Oral
• Transdermal
• Others

Global Motion Sickness Treatment Market, by Distribution Channel

• Retail Pharmacies
• Online Pharmacies
• Others (drug stores and hospital pharmacies)

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ https://www.linkedin.com/showcase/13221461
Follow me on : https://marketinfo247.wordpress.com/

Major Advancements Of Optical Lens Edger Market In Global Industry 2018-2026

ResearchMoz presents professional and in-depth study of "Optical Lens Edger Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026".

This market research report delves deep into the global Optical Lens Edger market. It highlights the recent market scenario, growth in the past few years, and opportunities present for manufacturers in the future. The research methods and tools used in the completion of this study are both primary and secondary. The study further presents details on the investments initiated by several organizations, institutions, government, and non-government bodies.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1598285

This report on the global optical lens edger market provides analysis for the period 2016–2026, wherein 2017 is the base year and 2018 to 2026 is the forecast period. Data for 2016 has been included as historical information. The report covers market dynamics, including drivers, restraints, opportunities, and trends expected to influence the growth of the optical lens edger market during the said period. The study provides comprehensive analysis on market growth throughout the above mentioned forecast period in terms of value and volume estimates (US$ Mn and Thousand Units) across different geographies.

Global Optical Lens Edger Market: Market Dynamics

The global optical lens edger market is projected to expand due to dynamic aspects such as rise in demand from the ophthalmology industry and impact of a rise in demand for camera products. However, the global optical lens edger market is facing a challenging environment from the three different aspects of maturity in the production cycle. Nevertheless, significant demand for in-office finishing labs in the ophthalmology industry is likely to offer attractive opportunities to the market. Simplified, effective, and automatic edging equipment are trending products in the global optical lens edger market.

Global Optical Lens Edger Market: Key Segments

The optical lens edger market has been segmented based on type, application, and region. Based on type, the global optical lens edger market has been classified into manual optical lens edger, automatic optical lens edger, and Semi-automatic optical lens edger. In terms of application, the global optical lens edger market has been categorized into eyeglass lens, microscope lens, camera lens, others (telescope, binoculars, etc.) Based on region, the report classifies the market into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South America.

Global Optical Lens Edger Market: Scope of the Study

The report highlights key developments in the optical lens edger market. Porter’s Five Force Analysis, which identifies bargaining power of suppliers, bargaining power of buyers, threat from new entrants, threat from substitutes, and degree of competition, is included in the report. Value chain analysis, which shows workflow in the optical lens edger market and identifies raw material service providers and distribution channels, are covered in the report. Segment trends and regional trends are part of the report. It also covers segment-wise comparison matrix, incremental opportunity analysis, and market positioning of key players for all regions covered in the scope of the study.

Incremental opportunity analysis identifies and compares attractiveness of segments based on CAGR and market share index across North America, Europe, Asia Pacific, Middle East & Africa, and South America along with all the countries included in these regions. The same has also been provided for the product segments.

Global Optical Lens Edger Market: Competitive Landscape

The report includes the competition landscape, which covers competition matrix and market share analysis of major players in the global optical lens edger market based on their 2017 revenues. It also includes profiles of major players. Competition matrix benchmarks leading players based on their capabilities and potential to grow. Factors such as market position, offerings, and R&D focus are attributed to a company’s capabilities. Topline growth, market share, segment growth, infrastructure facilities, and future outlook are attributed to a company’s potential to grow. This section also identifies and includes various recent developments by leading players in the optical lens edger market.

Company profiling includes company overview, major business strategies adopted, and key developments. The companies profiled in the global optical lens edger market include Essilor International S.A., Topcon Corporation, NIDEK CO., LTD., INNOVA Medical Ophthalmics Inc., Coburn Technologies Inc., Huvitz Corp., Mei Srl, Santinelli International, and Shanghai Supore Instruments Co. Ltd.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1598285

The global optical lens edger market is segmented as below:

Market Segmentation

Global Optical Lens Edger Market, by Type

    Manual Optical Lens Edger
    Automatic Optical Lens Edger
    Semi-automatic Optical Lens Edger

 Global Optical Lens Edger Market, by Application

    Eyeglass Lens
    Microscope Lens
    Camera Lens
    Others (Telescope, Binoculars, etc.)

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Technological Advancements Of Asthma Spacers Market In Global Industry 2018-2026

ResearchMoz presents professional and in-depth study of "Asthma Spacers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026".

The study presents an outline of the global Asthma Spacers market based on key parameters such as regions, products, technology, application, and end user. The projected volume and revenue growth of the global Asthma Spacers market during the forecast period has also been mentioned in the report. The report further offers an insight into the prime geographical segments of the global Asthma Spacers market and provides details about their past and present shares. The trends prevalent in the market have also been highlighted in the report. The study further presents an assessment of the factors that are expected to impact the growth of the market in a negative or positive way. The global Asthma Spacers market has been thoroughly analyzed with regard to the respective market segments and forecast period. Each year within the respective timeline has been briefly studied in terms of the value of the product in the regional as well as global market.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1598286

This report analyzes the current and future scenario of the global asthma spacers market. Rise in geriatric population, high prevalence of asthma, and increase in patient preference for the MDI/spacer combination are the major drivers of the global market.

The global asthma spacers market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product type, distribution channel, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by region, and market share analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global asthma spacers market.

Global Asthma Spacers Market: Key Segments

The global asthma spacers market has been segmented based on product type, distribution channel, and region. In terms of product type, the global market has been divided into aerochamber, optichamber, volumatic, inspirease, and others. The aerochamber segment is likely to account for a leading share of the global asthma spacers market during the forecast period, owing to wide adoption of aerochambers for the management of asthma. Technological developments in aerochamber are projected to boost the segment during the forecast period. Based on distribution channel, the global market has been classified into retail pharmacy, hospital pharmacy, and e-commerce. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Asthma Spacers Market: Regional Outlook

In terms of region, the global asthma spacers market has been segmented into five major regions and key countries/sub-regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (Saudi Arabia, Israel, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global asthma spacers market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key players in the global asthma spacers market are Koninklijke Philips N.V, Trudell Medical International, Medical Development International, Merck & Co., Pari Gmbh, AstraZeneca, and GlaxoSmithKline plc.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1598286

The global asthma spacers market has been segmented as below:

    Global Asthma Spacers Market, by Product Type
        Aerochamber
        Optichamber
        Volumatic
        Inspirease
        Others
    Global Asthma Spacers Market, by Distribution Channel
        Retail Pharmacy
        Hospital Pharmacy
        E-commerce

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Antimicrobial Ingredients Market : Structure And Overview Of Key Market Forces Propelling Market To 2026

ResearchMoz presents professional and in-depth study of "Antimicrobial Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026".

To present a comprehensive overview of the global Antimicrobial Ingredients market, the report carefully segments it based on various parameters such as geography, product type, services and others. The report also provides the values of each of these segments and individual growth rates during the forecast period. The dominant as well as emerging trends have been picked out. With handful of tables, charts, and graphs, the report carries extensive pictorial representation to support its findings.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1619895

The key role of antimicrobial ingredients in boosting the safety of products continues to drive their demand across multiple industries. Cosmetics and personal care products is observed as the single-most largest end-use industry for antimicrobial ingredients. With advancements in the formulations of cosmetic products, new ways of applying antimicrobial ingredients have been developed. In the near future, the demand for antimicrobial ingredients is expected to witness a considerable traction in the view of rising sales of skin care and hair care products.

Transparency Market Research has developed an exclusive forecast study and analysis report on the expansion of the global antimicrobial ingredients market for the assessment period, 2017-2026. To capture a global understanding, the report has quantified its market size forecasts in terms of volumes (tons). The report has used metrics such as absolute incremental opportunity, compound annual growth rate (CAGR), Year-on-Year (Y-o-Y) growth rate, and market share percentage to interpret the forecasted findings. The report has offered an overview of the cosmetics industry and also studied the role of antimicrobial ingredients in the production of cosmetics.

Global Antimicrobial Ingredients Market: Taxonomy

Key sections in the report provide segmental analysis on the expansion of the global antimicrobial ingredients market. Several geographies and regions have been analyzed to forecast the expansion of antimicrobial ingredients market thoroughly. Government initiatives and regulatory policies have been studied to weigh the attractiveness potential of regions. Production techniques have been examined to render cost-effectiveness index. The global antimicrobial ingredients market has been primarily segmented on the basis of product-type, end-use, form and region. Additional information on country-specific market size forecast is also provided in the report. Cross-segmental analysis of the global antimicrobial ingredients market is also provided in distinct sections of the report.

Global Antimicrobial Ingredients Market: Scope of the Report

This research report on the global antimicrobial ingredients market provides in-depth study on various techniques and materials used in the production of antimicrobial ingredients. From supply chain breakdown to cost structure analysis, the report has examined multiple aspects encompassing the production and end-use of antimicrobial ingredients. Latest trends in the cosmetics industry have been detailed in the report to gauge their impact on the production of antimicrobial ingredients. The study has observed the evolution of new and hybrid substances exhibiting high antimicrobial properties. Outcomes of recent scientific undertakings towards development of new antimicrobial ingredients have been studied. Moreover, factors influencing the market players to adopt synthetic sourcing of antimicrobial ingredients have also been analyzed in the report.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1619895

Inferences provided in the report are of great value for global antimicrobial ingredients market players. Each company partaking in the global production of antimicrobial ingredients can avail this report to assess insights on cost-effective production techniques, competitor analysis, and new avenues for applications. Changing landscapes of the cosmetics industry have been illustrated in the report, creating a roadmap of how antimicrobial ingredients secured their position in this rapidly-evolving industry. Market players can reform their strategies by assessing the market size forecast provided in the report. Lucrative marketplaces for antimicrobial ingredients have been revealed, which can influence the global expansion strategies of companies. Moreover, each antimicrobial ingredients producer has been profiled in detail in the study. With their current market standings revealed, the report has also exhibited the latest strategic developments of market players in an unbiased manner. The report serves as a credible business document that can help the players in the global antimicrobial ingredients market plan their next steps towards the direction of the market’s future.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

IoT Platforms for Telemedicine Market : Global Industry Analysis And Forecast Till 2023

ResearchMoz presents professional and in-depth study of "IoT Platforms for Telemedicine: Market Shares, Strategies, and Forecasts, Worldwide, 2017 to 2023".

The 2017 study has 234 pages, 115 tables and figures. Worldwide markets are poised to achieve significant growth as the digital economy takes hold with IOT Internet of things and all manner of automated medical monitoring processes increase the value of medical care while decreasing the costs.

IoT platforms for healthcare implement use of the digital economy. IoT for Telemedicine depends on infrastructure scalability excellence, which is achieved with a two layer architecture utilizing adapters and processors to manage sensor connectivity.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1354709

Healthcare stakeholders include payers, manufacturers, providers and physicians. Telemedicine IoT platforms provide the technology that implement a framework for transition from disjointed care to coordinated care. Platforms permit clinicians to be reactive to change in patient condition, permitting proactive care delivery.

“Remote healthcare grew 44% in 2016. The Intel® Health Application Platform helps enable innovation for greater adoption and effectiveness of secure remote patient care solutions. By offering a platform that supports gathering medical data at the edge of the network, devices are enabled that gather and distribute personal medical data securely to any cloud.”

IoT telemedicine platforms growth is brought by the combination the ability to lower the cost of medical care delivery while improving the quality of care dramatically. The IoT telemedicine platforms value goes beyond traditional medical monitoring bringing to the fore, the value of exercise. The value of exercise has been proven and telemedicine is anticipated to be used by exercise clubs to induce members to do more exercise that is beneficial to long term health. The value of supplemental oxygen in improving endurance and building muscles will likely become a part of telemedicine platform initiatives.

IoT Platforms for Telemedicine market forecast indicates that markets at $1.2 billion in 2016 are expected to reach $9.3 billion dollars worldwide by 2023. These represent a very specialized type of analytics systems able to address a wide range of issues that can be newly managed with digitization. Steady growth is anticipated because the IoT platform units are offering breakthrough digital information integration capabilities that further automates a delivery of care to a patient located remotely. Steady growth is anticipated because the IoT platforms are the best device for implementing efficient operations at low cost.

Companies Profiled

Market Leaders

Intel
IBM
Philips
Alibaba
Softbank
Apple
Google
Samsung

Market Participants

Alphabet / Google
Alibaba Group in Shanghai
Amazon
AMC Health
AMD Global
American Telehealth Association
American Well Systems
Apple
AT&T
Cisco
Doctor on Demand
GlobalMed
Google Chromecast
Hewlett HP IoT
IBM
iHealth Labs
Intel IoT Telemedicine Platforms
Microsoft IoT
Olea Kiosks
oneM2M Specifications for IoT Expansion
Philips
PTC
SAP
Sensogram Technologies
Softbank
Symantec / Norton Core Router
Teladoc
Vivify Health

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1354709

Companies Mentioned

Google, Amazon, Facebook
Accenture
Qualcomm
Niantic Pokémon Go
Novartis
Apple
Push Doctor
Babylon
McKesson
Onduo, a joint venture that Google’s health-care venture, Verily Life Sciences, and Sanofi, a French drug firm
Evolution Health
Philips
Guardant Health
Royal Free Hospital in London
DeepMind, a British artificial-intelligence (AI) research firm owned by Google
GE Healthcare, Siemens, Medtronic
Evolution Health
Guardant Health

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Follow me on : https://marketinfo247.wordpress.com/

Market Forecast Report On Antimicrobial Ingredients Market 2017-2026

ResearchMoz presents professional and in-depth study of "Antimicrobial Ingredients Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026".

Global Antimicrobial Ingredients Market: Holistic Outlook

The key role of antimicrobial ingredients in boosting the safety of products continues to drive their demand across multiple industries. Cosmetics and personal care products is observed as the single-most largest end-use industry for antimicrobial ingredients. With advancements in the formulations of cosmetic products, new ways of applying antimicrobial ingredients have been developed. In the near future, the demand for antimicrobial ingredients is expected to witness a considerable traction in the view of rising sales of skin care and hair care products.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1619895

Transparency Market Research has developed an exclusive forecast study and analysis report on the expansion of the global antimicrobial ingredients market for the assessment period, 2017-2026. To capture a global understanding, the report has quantified its market size forecasts in terms of volumes (tons). The report has used metrics such as absolute incremental opportunity, compound annual growth rate (CAGR), Year-on-Year (Y-o-Y) growth rate, and market share percentage to interpret the forecasted findings. The report has offered an overview of the cosmetics industry and also studied the role of antimicrobial ingredients in the production of cosmetics.

Global Antimicrobial Ingredients Market: Taxonomy

Key sections in the report provide segmental analysis on the expansion of the global antimicrobial ingredients market. Several geographies and regions have been analyzed to forecast the expansion of antimicrobial ingredients market thoroughly. Government initiatives and regulatory policies have been studied to weigh the attractiveness potential of regions. Production techniques have been examined to render cost-effectiveness index. The global antimicrobial ingredients market has been primarily segmented on the basis of product-type, end-use, form and region. Additional information on country-specific market size forecast is also provided in the report. Cross-segmental analysis of the global antimicrobial ingredients market is also provided in distinct sections of the report.

Global Antimicrobial Ingredients Market: Scope of the Report

This research report on the global antimicrobial ingredients market provides in-depth study on various techniques and materials used in the production of antimicrobial ingredients. From supply chain breakdown to cost structure analysis, the report has examined multiple aspects encompassing the production and end-use of antimicrobial ingredients. Latest trends in the cosmetics industry have been detailed in the report to gauge their impact on the production of antimicrobial ingredients. The study has observed the evolution of new and hybrid substances exhibiting high antimicrobial properties. Outcomes of recent scientific undertakings towards development of new antimicrobial ingredients have been studied. Moreover, factors influencing the market players to adopt synthetic sourcing of antimicrobial ingredients have also been analyzed in the report.

Inferences provided in the report are of great value for global antimicrobial ingredients market players. Each company partaking in the global production of antimicrobial ingredients can avail this report to assess insights on cost-effective production techniques, competitor analysis, and new avenues for applications. Changing landscapes of the cosmetics industry have been illustrated in the report, creating a roadmap of how antimicrobial ingredients secured their position in this rapidly-evolving industry. Market players can reform their strategies by assessing the market size forecast provided in the report. Lucrative marketplaces for antimicrobial ingredients have been revealed, which can influence the global expansion strategies of companies.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1619895

Moreover, each antimicrobial ingredients producer has been profiled in detail in the study. With their current market standings revealed, the report has also exhibited the latest strategic developments of market players in an unbiased manner. The report serves as a credible business document that can help the players in the global antimicrobial ingredients market plan their next steps towards the direction of the market’s future.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Follow me on : https://marketinfo247.wordpress.com/ 

Mobile Health (mHealth) Technologies : Global Industry Insights, Outlook And Forecast 2019

ResearchMoz presents professional and in-depth study of "Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017".

GBI Research’s latest report Mobile Health (mHealth) Technologies: Global Market Prospects – Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries – including organizations that already implement mHealth solutions and services, and those that do not.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1144778

The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI’s own analytical views to provide an assessment that is comprehensive in outlook.

mHealth is a branch of eHealth, and commonly defined as the use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers as well as policy markets. It can have a significant impact on consumers and on all aspects of the pharmaceutical and healthcare sector, and companies are making large investments to leverage these technologies more effectively. mHealth technologies are already a reality in both developed and developing countries, and their uptake is expected to significantly increase in the near future, particularly as the overall healthcare industry continues to shift towards value-based medicine, and due to the increasing need for more cost-effective means to deliver healthcare and to demonstrate the value and effectiveness of medical treatments.

The report features an overview of mHealth solutions and services and its place within the pharmaceutical industry. It examines the factors driving and necessitating the use of these technologies within this industry, and provides detailed examples of how different solutions could be used to provide direct benefits to pharmaceutical companies, healthcare institutions and patients. There is also an analysis of the main challenges surrounding these technologies, as well as case studies of how companies are already implementing mHealth, and deal with some of the challenges. Finally, based on the totality of the survey results and research, strategic recommendations are provided for the effective implementation of new mHealth initiatives.

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including results from key geographical markets. The survey examined key issues, such the areas where pharmaceutical organizations are currently utilizing mHealth; where they believe it can have the most impact; the main barriers to uptake and driving factors; the likelihood of increasing investment within the next five years; and the overall attitude towards the use of these technologies within the pharmaceutical industry.

GBI Research conducted extensive research to provide a comprehensive view of mHealth solutions and services. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.

Scope

    What are mHealth technologies. What is their place within the pharmaceutical industry.
    How prevalent is the use of mHealth technologies in the pharmaceutical, healthcare and healthcare IT industries.
    What are the main driving factors necessitating the use of mHealth. What is the relative importance of these factors.
    What are the commercial benefits that the use of mHealth solutions and services can provide across the pharmaceutical value chain.
    In which areas are organizations currently using mHealth, and where do they feel it will have the most impact in the next five years.
    What are the main challenges associated with mHealth technologies. What is the relative importance of these factors across key geographical markets. For the organizations that do not yet utilize mHealth solutions, what specific reasons have led to this decision.
    What is the likelihood that organizations that already use mHealth will increase their investment within the next five years. Will those that do not currently invest in the technology begin doing so over this period.
    How can mHealth initiatives be effectively implemented within an organization.
    What is the overall opinion of industry experts on the use of mHealth technologies.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1144778

Reasons To Buy

    Gain insightful analyses and comprehensive understanding of mHealth technologies
    Understand the key drivers necessitating the use of mHealth and the main barriers to implementation
    Understand the views of 65 different organizations within the industry on mHealth
    Assess the most relevant uses of mHealth solutions and services within your company, and effective ways of implementing mHealth initiatives

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Impact of Existing and Emerging mHealth (Mobile Healthcare) Market Trends And Forecast 2019-2030

ResearchMoz presents professional and in-depth study of "The mHealth (Mobile Healthcare) Ecosystem: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts".

A key enabler in the digital transformation of the healthcare industry, mobile healthcare - or mHealth - refers to the use of mobile connectivity and associated technologies across the healthcare continuum. Healthcare providers and payers are increasingly embracing mHealth as a means to enhance care coordination, maximize outreach, boost patient engagement and improve outcomes, while minimizing costs.

Keen to monetize their vast wireless network assets, mobile operators view mHealth as a substantial revenue opportunity - and many are extending beyond providing pure connectivity services, towards end-to-end mHealth offerings such as remote patient monitoring.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1808499

mHealth also offers a wealth of opportunities to the pharmaceutical industry, ranging from accelerated clinical trial innovation and medication adherence monitoring to securing the supply chain and combating counterfeit drugs. In addition, with the increasing prevalence of mobile apps that provide therapeutic impact, the digital therapeutics space is beginning to emerge, which may one day rival mainstream pharmaceuticals in areas such as chronic disease care.

Other stakeholders that are set to benefit from mHealth include but are not limited to connected medical and wearable device OEMs, app developers, Big Data and analytics specialists, cloud computing giants, and even ride-hailing providers such as Uber and Lyft - whose platforms are increasingly being integrated with healthcare IT systems, letting healthcare providers improve their level of care by booking rides for their patients.

Driven by the thriving ecosystem, SNS Telecom & IT estimates that the mHealth market will account for more than $28 Billion in 2018 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Telecom & IT estimates further growth at a CAGR of approximately 30% over the next three years.

The “mHealth (Mobile Healthcare) Ecosystem: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts“ report presents an in-depth assessment of the mHealth ecosystem including market drivers, challenges, enabling technologies, applications, key trends, standardization, regulatory landscape, case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for mHealth investments from 2018 till 2030. The forecasts are segmented for 5 submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered

The report covers the following topics:

    The scope and  implementation of mHealth across the globe
    mHealth technology
    Market drivers and key benefits of mHealth
    Challenges and inhibitors to the mHealth ecosystem
    mHealth standardization and regulatory initiatives
    mHealth opportunities, use cases and applications
    mHealth deployment case studies
    Value chain analysis of the mHealth ecosystem and the recognition of key players in each segment of the value chain
    mHealth future roadmap: 2018 – 2030
    Key trends in the mHealth ecosystem: cloud-based mHealth services, digital medicine, connected drug delivery, population health management, regulatory developments, and the impact of LTE/5G networks.
    The role of IoT and wearable technology in the mHealth ecosystem
    Profiles and strategies of over 310 leading and emerging mHealth ecosystem players
    Strategic recommendations for mobile operators, enabling technology providers, mHealth device OEMs, application developers, healthcare service providers and pharmaceutical companies

In-depth analysis for 5 individual submarkets and their associated mHealth application use cases:

    Pharmaceutical Applications
    Medical Information & Healthcare Management
    Healthcare & Fitness
    Remote Consultation/Diagnostic Services
    IoT, Wearable Technology, Sensor & Monitoring Applications
    Market analysis and forecasts from 2018 till 2030

Forecast Segmentation

Market forecasts are provided for each of the following 5 submarkets and their 23 use case categories:

Pharmaceutical Applications

    Safety Data Collection
    Consumer Education
    Medical Education
    Post–Market Monitoring
    Drug Authentication
    Social Media
    Patient Compliance & Retention: Clinical Trials

Information & Healthcare Management

    Electronic Health/Medical Records & Tracking Tools
    Diagnostic Tools & Medical Reference
    Continuing Medical Education
    Awareness Through Alerts
    Logistical & Payment Support

Healthcare & Fitness

    Medical Compliance
    Fitness & Nutrition Apps
    Clinical Decision Support Systems
    Prescribable Mobile Apps

Remote Consultation/Diagnostic Services

    Mobile Video Consultations, Collaboration & Surgery
    Non-Video Consultations & Collaboration
    Remote Collaboration in Emergency Situations

IoT, Wearable Technology, Sensor & Monitoring Applications

    Health and Wellness Monitoring
    Disease Surveillance/Remote Monitoring
    Diagnostic Tools
    Technical Logistics

Revenue is also split by ecosystem player:

Ecosystem Player Segmentation

    Mobile Operators & Connectivity Providers
    Mobile & mHealth Device OEMs
    Content & Application Providers
    Healthcare Service Providers
    Pharmaceutical Industry
    The following regional and country markets are also covered:

Regional Markets

    Asia Pacific
    Eastern Europe
    Latin & Central America
    Middle East & Africa
    North America
    Western Europe

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany,  India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK,  USA

Additional forecasts are provided for the following:

    IoT connections for mHealth applications
    Health and fitness-centric wearable device shipments
    Mobile video calling users
    Annual throughput of mobile network data traffic
    Smartphone, feature phone, tablet, desktop PC and notebook shipments
    Mobile network subscriptions by region
    Cost saving potential of mHealth by region
    Big Data & analytics technology investments in the healthcare sector

Key Questions Answered

The report provides answers to the following key questions:

    How big is the mHealth opportunity?
    What trends, challenges and barriers are influencing its growth?
    How is the ecosystem evolving by segment and region?
    What will the market size be in 2021 and at what rate will it grow?
    Which regions and countries will see the highest percentage of growth?
    How is the mHealth value chain structured and how will it evolve overtime?
    What level of cost savings can mHealth facilitate for healthcare service providers in each region?
    What will be the installed base of IoT connections for mHealth applications in 2021?
    How many mHealth-centric wearable devices will be shipped in 2021?
    Are digital therapeutics a threat to the pharmaceutical industry?
    What are the key applications of LTE and 5G networks in the mHealth arena?
    What considerations should be taken into account to devise a successful mHealth strategy for hospitals and other healthcare delivery environments?
    Who are the key ecosystem players and what are their strategies?
    What strategies should mobile operators, enabling technology providers, mHealth device OEMs, healthcare service providers, pharmaceutical companies and application developers adopt to capitalize on the mHealth opportunity?

Key Findings

The report has the following key findings:

    Driven by the thriving ecosystem, SNS Telecom & IT estimates that the mHealth market will account for more than $28 Billion in 2018 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Telecom & IT estimates further growth at a CAGR of approximately 30% over the next three years.
    With ongoing advances in key enabling technologies such as the miniaturization of sensors and the development of 5G NR (New Radio) platforms, a spate of new applications are beginning to emerge – ranging from connected drug delivery platforms to UHD (Ultra High Definition) video streaming for remote medical examinations.
    SNS Telecom & IT estimates that annual unit shipments of health and fitness-centric wearable devices will surpass 105 Million by the end of 2018. In order to gain valuable insights from the data generated by these devices, healthcare providers and other stakeholders are increasingly investing in Big Data and analytics technology.
    As key stakeholders realize the revenue potential of mHealth, a spate of prominent strategic partnerships are beginning to emerge. For example, pharmaceutical giant Novartis has recently partnered with digital therapeutics specialist Pear Therapeutics to co-develop prescription mobile apps aimed at treating patients with multiple sclerosis, schizophrenia and substance use disorder.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1808499

List of Companies Mentioned

    270 Vision
    3L Labs
    3M
    4DForce
    4iii Innovations
    Abbott Laboratories
    AbbVie
    Accenture
    Ada Health
    AdhereTech
    Adherium
    Adidas
    AeroScout
    Aerotel Medical Systems
    Aetna

Continue...

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Big Data in the Healthcare & Pharmaceutical Market Expected to Expand at a Steady CAGR through 2030

ResearchMoz presents professional and in-depth study of "Big Data in the Healthcare & Pharmaceutical Industry: 2018 - 2030 - Opportunities, Challenges, Strategies & Forecasts".

“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1863306

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

SNS Telecom & IT estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone.  Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.

The “Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.

The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.

Topics Covered

The report covers the following topics:

    Big Data ecosystem
    Market drivers and barriers
    Enabling technologies, standardization and regulatory initiatives
    Big Data analytics and implementation models
    Business case, application areas and use cases in the healthcare and pharmaceutical industry
    Over 40 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
    Future roadmap and value chain
    Profiles and strategies of over 270 leading and emerging Big Data ecosystem players
    Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
    Market analysis and forecasts from 2018 till 2030

Forecast Segmentation

Market forecasts are provided for each of the following submarkets and their subcategories:

Hardware, Software & Professional Services

    Hardware
    Software
    Professional Services

Horizontal Submarkets

    Storage & Compute Infrastructure
    Networking Infrastructure
    Hadoop & Infrastructure Software
    SQL
    NoSQL
    Analytic Platforms & Applications
    Cloud Platforms
    Professional Services

Application Areas

    Pharmaceutical & Medical Products
    Core Healthcare Operations
    Healthcare Support, Awareness & Disease Prevention
    Health Insurance & Payer Services
    Marketing, Sales & Other Applications

Use Cases

    Drug Discovery, Design & Development
    Medical Product Design & Development
    Clinical Development & Trials
    Precision Medicine & Genomics
    Manufacturing & Supply Chain Management
    Post-Market Surveillance & Pharmacovigilance
    Medical Product Fault Monitoring
    Clinical Decision Support
    Care Coordination & Delivery Management
    CER (Comparative Effectiveness Research) & Observational Evidence
    Personalized Healthcare & Targeted Treatments
    Data-Driven Preventive Care & Health Interventions
    Surgical Practice & Complex Medical Procedures
    Pathology, Medical Imaging & Other Medical Tests
    Proactive & Remote Patient Monitoring
    Predictive Maintenance of Medical Equipment
    Pharmacy Services
    Self-Care & Lifestyle Support
    Digital Therapeutics
    Medication Adherence & Management
    Vaccine Development & Promotion
    Population Health Management
    Connected Health Communities & Medical Knowledge Dissemination
    Epidemiology & Disease Surveillance
    Health Policy Decision Making
    Controlling Substance Abuse & Addiction
    Increasing Awareness & Accessible Healthcare
    Health Insurance Claims Processing & Management
    Fraud & Abuse Prevention
    Proactive Patient Engagement
    Accountable & Value-Based Care
    Data-Driven Health Insurance Premiums
    Marketing & Sales
    Administrative & Customer Services
    Finance & Risk Management
    Healthcare Data Monetization
    Other Use Cases

Regional Markets

    Asia Pacific
    Eastern Europe
    Latin & Central America
    Middle East & Africa
    North America
    Western Europe

Country Markets

Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany,  India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK,  USA

Key Questions Answered

The report provides answers to the following key questions:

    How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
    How is the market evolving by segment and region?
    What will the market size be in 2021, and at what rate will it grow?
    What trends, challenges and barriers are influencing its growth?
    Who are the key Big Data software, hardware and services vendors, and what are their strategies?
    How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
    What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
    Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?

Key Findings

The report has the following key findings:

    In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of approximately 12% over the next three years, eventually accounting for more than $7 Billion by the end of 2021.
    Big Data and advanced analytics are driving a paradigm shift in the healthcare and pharmaceutical industry with multiple innovations ranging from precision medicine and digital therapeutics to the adoption of accountable and value-based care models.
    Drug developers are making substantial investments in Big Data and artificial intelligence-driven drug discovery platforms to shorten the process of successfully discovering promising compounds. In addition, Big Data technologies are increasingly being utilized to streamline clinical trials, enabling biopharmaceutical companies to significantly lower costs and accelerate productive trials.
    The growing adoption of Big Data technologies has also brought about an array of benefits for hospitals and other healthcare facilities. Based on feedback from healthcare providers worldwide, these include but are not limited to cost savings in the range of 20-30%, an increase in patient access to services by more than 35%, growth in revenue by up to 30%, a reduction in emergency room visits by 10%, a drop in patient wait times by 30-60%, improvements in outcomes by as much as 20%, a 10-50% decline in mortality rates for conditions such as heart failure, and a reduction in the occurrence of hospital acquired and surgical site infections by nearly 60%.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1863306

List of Companies Mentioned

    1010 data
    AbbVie
    Absolutdata
    Accenture
    ACR (American College of Radiology)
    Actian Corporation
    Adaptive Insights
    Adobe Systems
    Advizor Solutions
    AeroSpike
    Aetna
    AFS Technologies
    Alation
    Algorithmia
    Alluxio
    Alphabet
    ALTEN
    Alteryx
    Ambient Clinical Analytics
    Ambulance Victoria
    AMD (Advanced Micro Devices)
    Amino
    Anaconda
    Apixio
    Arcadia Data
    Arimo
    ARM
    ASF (Apache Software Foundation)
    ASTM (American Society for Testing and Materials)
    AstraZeneca
    Atomwise
    AtScale
    Attivio
    Attunity
    Australian Digital Health Agency
    Automated Insights
    AVORA
    AWS (Amazon Web Services)
    Axiomatics
    Ayasdi
    BackOffice Associates
    Bangkok Hospital Group
    Basho Technologies
    Bayer
    BCG (Boston Consulting Group)
    Bedrock Data
    BetterWorks
    Big Panda
    BigML
    Birst
    Bitam
    Blue Medora
    BlueData Software
    BlueTalon
    BMC Software
    BMS (Bristol-Myers Squibb)
    BOARD International
    Booz Allen Hamilton
    Boxever
    CACI International
    Cambridge Semantics
    Capgemini
    Cazena
    Centerstone
    Centrifuge Systems

Continue...

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Latest Market Research Report Announced on High Content Screening/Imaging Market in Global Industry 2019 to 2023

ResearchMoz presents professional and in-depth study of "High Content Screening/Imaging: Technologies and Global Markets".

Summary

High content screening (HCS) is a technique that has been developed to collect quantitative data from cell populations. The market is growing at a CAGR of REDACTED and is expected to reach REDACTED in 2023, up from REDACTED in 2017. HCS systems allow relatively high throughput screening of cells, in which each cell in an array would be analyzed at a subcellular resolution using multicolored, fluorescence-based reagents for both specificity and sensitivity.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1929769

The method is integrated with analytical tools such asmicroscopy, multiparameter image processing, and visualization tools. HCS integrates the instrumentation, application software, reagents, sample preparation, and informatics and bioinformatics required to rapidly flow from producing data, generating information, and ultimately creating new cellular knowledge. High content screening is increasingly being adopted in biological research and drug discovery. Additionally, it is being implemented in oncology, neuroscience, and oncology research, including primary compound screening and post-primary screening. Recently, high content approaches have been used extensively in stem cell biology.

The major factors contributing to the growth of the HCS market is the rising adoption of high content screening technology in research and development activities. The rapid adoption of HCS technology in the pharmaceutical industry and academic research center indicates the importance of this informationrich screening tool. The imaging of cell function has become increasingly important to understand the underlying functional biology associated with new therapeutic targets. Demand for improved technologies for cell research, government support and emergence of sophisticated informatics solutions, and rising demand for better screening systems is augmenting the demand for high content imaging within fully automated screening laboratories. Furthermore, technological advancements and developments in biological research and the discovery of more effective therapies for the treatment of human disease is fueling the growth of the market. HCS imaging systems have continually evolved with many improvements enabled to meet user demands of greater flexibility and the growing requirements of assays involving complex cellular disease models. Increasing drug discovery R&D globally, increasing investments and introduction of advanced imaging instruments are the other drivers for the HCS market.

The high cost of HCS instrumentation is the primary factor restraining the growth of the market. The price of machinery and instrumentation prohibits a small economy country or a research organization from purchasing HCS equipment. Companies are introducing more sensitive cameras and better light sources such as LED and multicolor illumination, which are increasing the output and reliability of the system and, therefore, the overall cost of the microscopes. The price of HCS equipment varies from a hundred thousand to a million, depending on the specifications. Inadequate infrastructure and less funding for R&D in emerging countries will also hinder the market as installation and maintenance costs are also very high and not easily feasible for emerging economies.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/high-content-screeningimaging-technologies-and-global-markets-report.html/toc

Adoption of HCS in the analysis of 3D spheroids, microtissues and phenotypic assays, are expected to impact gene editing studies based on CRISPR-Cas9 in the future. Moreover, the growing availability of perturbagen libraries and HCS infrastructure within academic research centers has prompted widespread interest in HCS applications among academic investigators. The combination of HCS with chemical genetics, where small organic molecules are used to study biological systems has emerged as a powerful approach for defining protein functions and dissecting signaling pathways. The rapid growth of genome-wide RNA interference (RNAi) technology to probe gene function in mammalian cell culture systematically have popularized HCS systems in academic research environments.

Report Scope

The HCS/I market has significant potential due to rising demand from the drug discovery and molecular diagnosis segments. The capabilities and possibilities of HCS/I market growth increases with the growth of new technologies and technological advancements. Emerging economies such as China, India, and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the market. Investments and funding from government and private ventures, research institutes and universities are supporting exploration into the potential of this market. Growing drug discovery and molecular diagnostic and research through HCS/I will further boost the market in the near future. The global rise in infectious and noninfectious diseases, growing populations, technological advancements and innovation are other factors creating considerable demand for HCS/I.

The scope of this study encompasses the current market for drug discovery, molecular diagnostics, cancer research, personalized medicine and compound profiling. The report also includes regulatory aspects, recent developments, market projections, competitive landscapes and market share. Analyses of patents, clinical trials, innovations and opportunities, as well as the latest trends, are also discussed in the report. The report intends to explain the key trends of HCS/I technologies and applications in various geographies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.

Report Includes:

- 38 data tables and 23 additional tables
- An overview of the global markets for high content screening/imaging technologies
- Analyses of global market trends, with data from 2017, estimated from 2018 and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of various microscope and imaging technologies in the industry
- Detailed analysis of the technological advancement in cytometers, light sources, detectors/sensors and liquid handling instruments
- Discussion of the various market motivators i.e. increasing R&D budget, advantages over manual and HTS, technological advancement, and automation

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1929769

- Company profiles of major players in the industry, including Albany Molecular Research, Inc. (AMRI), Cell Signaling Technology, Danaher Corp., GE Healthcare and Instrument Systems

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Development of Connected Medical Device Technologies Market in Global Industry : Research and Forecast 2019-2021

ResearchMoz presents professional and in-depth study of "Connected Medical Device Technologies: Global Markets for Sensors, Platforms and Processors".

Report Highlights

The global market for connected medical device technologies reached nearly $5.0 billion in 2016 and should reach $8.3 billion by 2021, at a compound annual growth rate (CAGR) of 10.8% from 2016 through 2021.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377181

Report Includes

    An overview of the global market for connected medical device technologies.
    Analyses of global market trends with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
    Discussion of underlying technologies driven by the connected medical device trend.
    An in-depth analysis of CMD technologies by type: specifically connected medical device sensors, platforms and processors.
    Information on the changing regulatory landscape and competitive dynamics, including critical success factors, such as research and development capability, installed base, branding and ecosystem influence, and partnerships.
    Profiles of major players in the industry.

Report Scope

This report covers the global market for connected medical devices and a regional analysis of North America, Latin America, Europe, Middle East and Africa and Asia-Pacific. Component segments include sensors (temperature, position, pressure, flow, level and other), platforms (connectivity, data application integration, device management) and processors. Other technologies such as chemical, force, image, SQUID, biosensors and spintronics are discussed qualitatively. The market for embedded microprocessors and microcontrollers is also sized and analyzed.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/connected-medical-device-technologies-global-markets-for-sensors-platforms-and-processors-report.html/toc

Table Of Contents

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background
Origin of Connected Medical Devices
Connected Medical Device Types
Regulatory Environment
Standards
Interoperability

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377181

Chapter 4 Market Breakdown by Technology Type
Sensors for Medical Devices
Role of Sensors in Connected Medical Devices
Growth Drivers
Types of Sensors
Sensor Requirements of OEMs
Connected Medical Device Platforms

Chapter 5 Market Breakdown by End Use

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Market Study : Global Mobile Health (mHealth) Technologies Market Prospects - Featuring Expert Panel Views from Industry Survey 2019

ResearchMoz presents professional and in-depth study of "Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017".

GBI Research’s latest report Mobile Health (mHealth) Technologies: Global Market Prospects – Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries – including organizations that already implement mHealth solutions and services, and those that do not.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1144778

The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI’s own analytical views to provide an assessment that is comprehensive in outlook.

mHealth is a branch of eHealth, and commonly defined as the use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers as well as policy markets. It can have a significant impact on consumers and on all aspects of the pharmaceutical and healthcare sector, and companies are making large investments to leverage these technologies more effectively. mHealth technologies are already a reality in both developed and developing countries, and their uptake is expected to significantly increase in the near future, particularly as the overall healthcare industry continues to shift towards value-based medicine, and due to the increasing need for more cost-effective means to deliver healthcare and to demonstrate the value and effectiveness of medical treatments.

The report features an overview of mHealth solutions and services and its place within the pharmaceutical industry. It examines the factors driving and necessitating the use of these technologies within this industry, and provides detailed examples of how different solutions could be used to provide direct benefits to pharmaceutical companies, healthcare institutions and patients. There is also an analysis of the main challenges surrounding these technologies, as well as case studies of how companies are already implementing mHealth, and deal with some of the challenges. Finally, based on the totality of the survey results and research, strategic recommendations are provided for the effective implementation of new mHealth initiatives.

The results of GBI’s latest industry survey provide insightful analyses from different expert panels, including results from key geographical markets. The survey examined key issues, such the areas where pharmaceutical organizations are currently utilizing mHealth; where they believe it can have the most impact; the main barriers to uptake and driving factors; the likelihood of increasing investment within the next five years; and the overall attitude towards the use of these technologies within the pharmaceutical industry.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/mobile-health-mhealth-technologies-global-market-prospects-featuring-expert-panel-views-from-industry-survey-2017-report.html/toc

GBI Research conducted extensive research to provide a comprehensive view of mHealth solutions and services. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.

Scope

    What are mHealth technologies. What is their place within the pharmaceutical industry.
    How prevalent is the use of mHealth technologies in the pharmaceutical, healthcare and healthcare IT industries.
    What are the main driving factors necessitating the use of mHealth. What is the relative importance of these factors.
    What are the commercial benefits that the use of mHealth solutions and services can provide across the pharmaceutical value chain.
    In which areas are organizations currently using mHealth, and where do they feel it will have the most impact in the next five years.
    What are the main challenges associated with mHealth technologies. What is the relative importance of these factors across key geographical markets. For the organizations that do not yet utilize mHealth solutions, what specific reasons have led to this decision.
    What is the likelihood that organizations that already use mHealth will increase their investment within the next five years. Will those that do not currently invest in the technology begin doing so over this period.
    How can mHealth initiatives be effectively implemented within an organization.
    What is the overall opinion of industry experts on the use of mHealth technologies.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1144778

Reasons To Buy

    Gain insightful analyses and comprehensive understanding of mHealth technologies
    Understand the key drivers necessitating the use of mHealth and the main barriers to implementation
    Understand the views of 65 different organizations within the industry on mHealth
    Assess the most relevant uses of mHealth solutions and services within your company, and effective ways of implementing mHealth initiatives

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

Major Advancements Of Oncology Information System Market in Global Industry 2019-2022

ResearchMoz presents professional and in-depth study of "Oncology Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022".

Global Oncology Information System Market: Overview

The global oncology information system market report presents a comprehensive view of the market in order to familiarize readers with the overall composition of the oncology information system market and the dynamics affecting its growth trajectory in the coming years. The global oncology information system market is profiled in the report with the help of detailed assessments of the market’s competitive dynamics, leading players, and major segments.

Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1351279

The comprehensive market assessment provided in the report is backed by reliable databases illustrating the historical trajectory of the oncology information systems and solid analytical models providing a clear look at how the market is likely to develop over the coming years.

The global oncology information systems market was valued at close to US$2.3 bn in 2017 and is likely to rise to US$3.3 bn by 2022 at a solid CAGR of 7.6% therein.

Global Oncology Information System Market: Dynamics

The report provides readers with detailed information regarding the major factors affecting the development of the oncology information system market and what role they are likely to play in the growth of the market in the coming years. The effect of major drivers on the oncology information system market is assessed quantitatively and qualitatively in the report to provide a clear picture of which factors are likely to have a lasting impact on the market. The analysis of the major restraints facing the global oncology information system market will also help readers assess which risks threaten their operations in the market in the coming years and how to overcome or avoid them in the coming years.

The major drivers working for the global oncology information system market are the rising prevalence of cancer across the world and particularly the rising incidence of cancer recurrence among cancer patients, the increasing use of digital tools in the healthcare sector, and the rising government support to cancer research. Nevertheless, the absence of favorable regulatory scenarios for oncology information systems is likely to offset the growth prospects of the oncology information system market in the coming years.

Global Oncology Information System Market: Segmentation

The report analyzes the segmentation of the global oncology information system market in detail to give readers a clear picture of the granular composition of the market. Historical information about the leading segments of the oncology information system is provided in the report in terms of the 2012-2017 growth trajectory of the segments. This provides a solid foundation to reliable predictions regarding the way the segments are likely to evolve over the coming years and how they are likely to contribute to the global oncology information system market.

View Complete TOC with tables & Figures @ https://www.researchmoz.us/oncology-information-system-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2022-report.html/toc

By service type, the report segments the global oncology information system market into patient information systems, treatment planning systems, consulting services, implementation services, and post-sale and maintenance services. Patient information services are likely to remain the dominant segment of the global oncology information system market in the coming years and are expected to account for close to 34% of the market in 2022.

By end use, the report segments the global oncology information system market into hospitals, oncology clinics, governmental institutions, and research centers. By application, the oncology information system market is segmented into radiation oncology, surgical oncology, and medical oncology.

Geographically, North America is likely to remain the dominant contributor to the global oncology information system market. The region is expected to exhibit a strong 8.6% CAGR over the 2017-2022 forecast period to emerge at a valuation of US$1,411.5 mn by 2022.

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1351279

Competitive Dynamics

The report devotes a major part to analyzing the competitive dynamics of the global oncology information system market in order to familiarize readers with the workings of the market. Leading oncology information system market players profiled in the report include Accuray Inc., Koninklijke Philips N.V., Cerner Corporation, Mckesson Corporation, Flatiron Health Inc., Raysearch Laboratories, Epic Systems Corporation, Verian Medical Systems Inc., and Elekta AB.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/